Edge Therapeutics, Inc.
Edge Therapeutics, Inc. (EDGE) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 110 transactions totaling $16.5M, demonstrating a bullish sentiment with $13.7M in net insider flow. The most recent transaction on Mar 15, 2019 involved a transaction of 20,000 shares valued at $0.
EDGE Insider Activity Summary
Who Is Buying EDGE Stock?
No significant insider buying has been recorded for EDGE in the recent period.
Who Is Selling EDGE Stock?
No significant insider selling has been recorded for EDGE in the recent period.
Is Edge Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EDGE is bullish with an Insider Alignment Score of 91/100 and a net flow of $13.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
EDGE Frequently Asked Questions
Understanding EDGE Insider Activity
Insider trading at Edge Therapeutics, Inc. (EDGE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading EDGE stock, having executed 110 transactions in the past 90 days. The most active insider is James Healy (Executive), who has made 4 transactions totaling $9.4M.
Related Tools
Track Edge Therapeutics, Inc. Insider Activity
Get notified when executives and directors at EDGE file new Form 4 transactions